G-Cimp Status Prediction Of Glioblastoma Samples Using mRNA Expression Data

• Mehmet Baysan,

  Affiliation Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Serdar Bozdag,

  Affiliation Department of Mathematics, Statistics, and Computer Science, Marquette University, Milwaukee, Wisconsin, United States of America

  ⨯
• Margaret C. Cam,

  Affiliation Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Svetlana Kotliarova,

  Affiliation Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Susie Ahn,

  Affiliation Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Jennifer Walling,

  Affiliation Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Jonathan K. Killian,

  Affiliation Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Holly Stevenson,

  Affiliation Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Paul Meltzer,

  Affiliation Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Howard A. Fine

  * E-mail: Howard.Fine@nyumc.org

  Affiliations Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America, New York University Cancer Institute, New York University Langone Medical Center, New York, New York, United States of America

  ⨯